Clark Capital Management Group, Inc. Ligand Pharmaceuticals Inc Transaction History
Clark Capital Management Group, Inc.
- $13.8 Billion
- Q4 2024
A detailed history of Clark Capital Management Group, Inc. transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Clark Capital Management Group, Inc. holds 37,277 shares of LGND stock, worth $4.03 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
37,277
Previous 25,821
44.37%
Holding current value
$4.03 Million
Previous $2.59 Million
54.45%
% of portfolio
0.03%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding LGND
# of Institutions
277Shares Held
18.5MCall Options Held
30.8KPut Options Held
5.2K-
Black Rock Inc. New York, NY2.87MShares$311 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.09MShares$226 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.02MShares$110 Million0.06% of portfolio
-
Macquarie Group LTD Australia, C3884KShares$95.6 Million0.11% of portfolio
-
State Street Corp Boston, MA744KShares$80.4 Million0.0% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $1.83B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...